Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples

作者: David T. Dunn , RJ Simonds , Marc Bulterys , Leslie A. Kalish , Jack Moye

DOI: 10.1097/00002030-200007070-00016

关键词:

摘要: Objective To determine whether mode of delivery or the use maternal neonatal antiretroviral prophylaxis influence age when HIV-1 can first be detected in infected infants, particularly probability detection at birth. Methods In a collaboration between four multicentre studies, data on 422 infants who were assessed by DNA PCR cell culture before 14 days analysed. Weibull mixture models used to estimate cumulative proportion with detectable levels according maternal/neonatal therapy (mainly zidovudine monotherapy) and delivery. Results was 162 (38%) they tested, median 2 days. At birth, it estimated that 36% [95% confidence interval (CI), 31–41%] have virus culture. This percentage not associated either (35% for vaginal versus 40% cesarean section delivery;P  = 0.4) prophylaxis. Among undetectable time viral detectability 14.8 (95% CI, 12.9–16.8 days). increased 15% −11 48%;P  = 0.3) among exposed postnatally compared exposed. No effect observed Conclusions The outcome an early virological test is thought related directly timing transmission primarily reduces risk intrapartum transmission. absence association birth therefore unexpected. There no evidence foetal exposure prophylactic delays substantially diagnosis infection, although this cannot inferred combination therapy.

参考文章(27)
David E Shapiro, Rhoda S Sperling, Robert W Coombs, None, Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load The Lancet. ,vol. 354, pp. 156- ,(1999) , 10.1016/S0140-6736(99)00122-1
Thea Dm, Kuhn L, Tsai Wy, Abrams Ej, Chinchilla M, SENSITIVITY OF HIV-1 DNA POLYMERASE CHAIN REACTION IN THE NEONATAL PERIOD AIDS. ,vol. 10, pp. 1181- 1182 ,(1996)
Proposed definitions for in utero versus intrapartum transmission of HIV-1. The New England Journal of Medicine. ,vol. 327, pp. 1246- 1247 ,(1992) , 10.1056/NEJM199210223271718
Jane C. Lindsey, Louise M. Ryan, Tutorial in biostatistics methods for interval-censored data. Statistics in Medicine. ,vol. 17, pp. 219- 238 ,(1998) , 10.1002/(SICI)1097-0258(19980130)17:2<219::AID-SIM735>3.0.CO;2-O
Christian Kind, Christoph Rudin, Claire-Anne Siegrist, Claire-Anne Wyler, Kurt Biedermann, Urs Lauper, Olivier Irion, Jörg Schüpbach, David Nadal, Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group. AIDS. ,vol. 12, pp. 205- 210 ,(1998) , 10.1097/00002030-199802000-00011
Laurent Mandelbrot, Jérôme Le Chenadec, Alain Berrebi, André Bongain, Jean-Louis Bénifla, Jean-François Delfraissy, Stéphane Blanche, Marie-Jeanne Mayaux, for the French Perinatal Cohort, Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA. ,vol. 280, pp. 55- 60 ,(1998) , 10.1001/JAMA.280.1.55
Robert J. Biggar, Laban Mtimavalye, Aafke Justesen, Robin Broadhead, Wendel Miley, David Waters, James J. Goedert, John D. Chiphangwi, Taha E. Taha, Paolo G. Miotti, Does umbilical cord blood polymerase chain reaction positivity indicate in utero (pre-labor) HIV infection? AIDS. ,vol. 11, pp. 1375- 1382 ,(1997) , 10.1097/00002030-199711000-00012
A. Krivine, L. Cao, P. Lebon, C. Francoual, G. Firtion, R. Henrion, HIV replication during the first weeks of life The Lancet. ,vol. 339, pp. 1187- 1189 ,(1992) , 10.1016/0140-6736(92)91131-Q
Tomoharu Kaneda, Kazuo Shiraki, Karuyuki Hirano, Ikuo Nagata, Detection of Maternofetal Transfusion by Placental Alkaline Phosphatase Levels. The Journal of Pediatrics. ,vol. 130, pp. 730- 735 ,(1997) , 10.1016/S0022-3476(97)80014-5